Department of Pharmacology, School of Pharmacy, Nantong University, #19 Qixiu Road, Nantong 226001, Jiangsu, China.
Department of Pharmacy, Yancheng First Hospital, the Fourth Affiliated Hospital of Nantong University, #66 Renmin South Road, Yancheng 224006, Jiangsu, China.
Brain Behav Immun. 2022 Oct;105:44-66. doi: 10.1016/j.bbi.2022.06.015. Epub 2022 Jul 1.
Our previous studies had reported that microglia activation one day before stress exposure prevented the behavioral abnormalities induced by chronic stress in adult mice, and a 10-day interval between microglia stimulation and stress exposure can abolish the prophylactic effect of LPS preinjection on the behavioral abnormalities induced by chronic stress, which, however, could be rescued by repeated LPS injection. This suggests that increased stimulation of microglia results in animals developing a strong ability to prevent deleterious stress stimuli. Because microglia in the adolescent brain exhibit flexible immunological plasticity, we hypothesize that a single low-dose LPS injection during adolescence may provide long-lasting protection against behavioral abnormalities induced by chronic stress in adult mice. As expected, our results showed that a single injection of LPS (100 μg/kg) at post-natal day 28 (PND 28) prevented the development of abnormal behaviors and shifted neuroinflammatory responses toward an anti-inflammatory phenotype in adult mice treated with CSDS at their different stages of the age (PND 56, 140, and 252). Moreover, pretreatment with minocycline or PLX3397 to inhibit microglial activation abolished the prophylactic effect of LPS preinjection after PND 28 on behavioral abnormalities and neuroinflammatory responses induced by CSDS in adult mice at their different stages of the age, PND 56, 140, and 252. These results indicate that stimulation of microglia in adolescence may confer long-lasting protection against neuroinflammatory responses and behavioral abnormalities induced by chronic stress in adult mice. This may offer the potential for the development of a "vaccine-like strategy" to prevent mental disorders.
我们之前的研究报告表明,在应激暴露前一天激活小胶质细胞可以预防成年小鼠慢性应激引起的行为异常,而在小胶质细胞刺激和应激暴露之间间隔 10 天可以消除 LPS 预先注射对慢性应激引起的行为异常的预防作用,但可以通过重复 LPS 注射来挽救。这表明小胶质细胞的过度刺激导致动物产生了更强的预防有害应激刺激的能力。由于青春期大脑中的小胶质细胞表现出灵活的免疫可塑性,我们假设在青春期单次低剂量 LPS 注射可能为成年小鼠慢性应激引起的行为异常提供持久的保护。不出所料,我们的结果表明,在 PND 28 时单次注射 LPS(100μg/kg)可预防异常行为的发生,并在 CSDS 处理的成年小鼠的不同年龄阶段(PND 56、140 和 252)将神经炎症反应转向抗炎表型。此外,预先用米诺环素或 PLX3397 抑制小胶质细胞激活可消除 PND 28 时 LPS 预先注射对 CSDS 在成年小鼠不同年龄阶段(PND 56、140 和 252)引起的行为异常和神经炎症反应的预防作用。这些结果表明,青春期小胶质细胞的刺激可能为成年小鼠慢性应激引起的神经炎症反应和行为异常提供持久的保护。这可能为开发预防精神障碍的“疫苗样策略”提供了潜力。